Results of the GIANT trial reported at TCT 2013

(Cardiovascular Research Foundation) According to a new study, genetic profiling of patients undergoing percutaneous coronary intervention may help cardiology teams adjust treatment and improve ischemic outcomes for patients that do not properly metabolize thienopyridine blood thinning therapies such as clopidogrel.

Source: EurekAlert! - Medicine and Health - October 31, 2013 Category: Global & Universal Source Type: news